Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001
-
Shares outstanding
-
154M
-
Number of holders
-
97
-
Total 13F shares, excl. options
-
37.9M
-
Shares change
-
+4.81M
-
Total reported value, excl. options
-
$553M
-
Value change
-
+$48.5M
-
Put/Call ratio
-
0.53
-
Number of buys
-
63
-
Number of sells
-
-29
-
Price
-
$14.60
Significant Holders of Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) as of Q2 2022
118 filings reported holding ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 as of Q2 2022.
Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) has 97 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37.9M shares
of 154M outstanding shares and own 24.61% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (7.45M shares), RTW INVESTMENTS, LP (3.95M shares), COWEN AND COMPANY, LLC (2.44M shares), Abingworth LLP (2.12M shares), BlackRock Inc. (1.85M shares), Cormorant Asset Management, LP (1.8M shares), MORGAN STANLEY (1.63M shares), Polar Capital Holdings Plc (1.54M shares), Candriam S.C.A. (1.28M shares), and VANGUARD GROUP INC (1.24M shares).
This table shows the top 97 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.